Combination Laser Platform Treats Glaucoma and Cataract
By HospiMedica International staff writers Posted on 22 Jul 2014 |
Image: The Optimis Fusion integrated laser platform (Photo courtesy of Quantel Medical).
An integrated laser offers ophthalmologists a versatile armamentarium for treating both cataract and glaucoma in an efficient combination platform.
The Optimis Fusion integrated laser combines advanced selective laser trabeculoplasty (SLT) photoregeneration therapy and traditional yttrium aluminium garnet (YAG) photodisruption to provide a platform for managing glaucoma and lowering intraocular pressure. The SLT therapy works by targeting melanin-rich cells that absorb the laser energy to induce a healing response, improving the function of the trabecular meshwork. Laser energy is delivered in short, fixed pulses over a large, homogeneous spot size, resulting in no thermal damage to the trabecular meshwork, making it a repeatable procedure.
The YAG mode delivers high-performance photodisruption for capsulotomy and peripheral iridotomy surgical procedures. The gaussian laser beam profile allows for precise laser delivery at minimum energy levels, avoiding adverse side effects such as lens pitting. Precise tissue targeting is achieved with the advanced two-point aiming beam, allowing for fast and accurate targeting of the capsule, and an adjustable anterior and posterior offset feature for easy focus adjustment in front of, behind, or at the point of disruption. The Optimis Fusion integrated laser is a product of Quantel Medical (Clermont-Ferrand, France).
“We are extremely excited to bring our breakthrough laser platform to the US market,” said Jean-Marc Gendre, CEO of Quantel Medical. “The Optimis Fusion has proven to be a very attractive laser platform since introduction earlier this year in other markets. Driving the acceptance of this product introduction is the ability to combine a 532 nm monospot or multispot retina laser, a unique feature to Quantel's laser line.”
Related Links:
Quantel Medical
The Optimis Fusion integrated laser combines advanced selective laser trabeculoplasty (SLT) photoregeneration therapy and traditional yttrium aluminium garnet (YAG) photodisruption to provide a platform for managing glaucoma and lowering intraocular pressure. The SLT therapy works by targeting melanin-rich cells that absorb the laser energy to induce a healing response, improving the function of the trabecular meshwork. Laser energy is delivered in short, fixed pulses over a large, homogeneous spot size, resulting in no thermal damage to the trabecular meshwork, making it a repeatable procedure.
The YAG mode delivers high-performance photodisruption for capsulotomy and peripheral iridotomy surgical procedures. The gaussian laser beam profile allows for precise laser delivery at minimum energy levels, avoiding adverse side effects such as lens pitting. Precise tissue targeting is achieved with the advanced two-point aiming beam, allowing for fast and accurate targeting of the capsule, and an adjustable anterior and posterior offset feature for easy focus adjustment in front of, behind, or at the point of disruption. The Optimis Fusion integrated laser is a product of Quantel Medical (Clermont-Ferrand, France).
“We are extremely excited to bring our breakthrough laser platform to the US market,” said Jean-Marc Gendre, CEO of Quantel Medical. “The Optimis Fusion has proven to be a very attractive laser platform since introduction earlier this year in other markets. Driving the acceptance of this product introduction is the ability to combine a 532 nm monospot or multispot retina laser, a unique feature to Quantel's laser line.”
Related Links:
Quantel Medical
Latest Surgical Techniques News
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots